All posts tagged "Regeneron Pharmaceuticals"

• 

  12.2K

  6

  Biotech

  Leronlimab Trial Results All But Certain Pointing to Approval For CytoDyn

  CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...

• 

  16.5K

  2

  Biotech

  Wading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)

  CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...

• 

  21.5K

  Biotech

  Top Coronavirus Stocks backed by Scientific Evidence

  Developing a vaccine to treat COVID-19 is hands down the best way to play the long term coronavirus stocks.  Ultimately a vaccine...

• Stocks

  Trending Tickers: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), American International Group, Inc. (NYSE:AIG), Myriad Genetics Inc. (NASDAQ:MYGN), Carlisle Companies (NYSE:CSL), Banc of California (NYSE:BANC)

  Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) cut the top end of its sales forecast for the blockbuster eye drug Eylea, citing slower adoption by...

• Stocks

  Announcement Affects: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), SinoCoking Coal and Coke Chemical Industries, Inc. (NASDAQ:SCOK), Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

  Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (SNY) released that the first patients have been dosed in a Phase 3 clinical study of...

• Stocks

  Trending Stocks : Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), Nektar Therapeutics (NASDAQ:NKTR), Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX), United Microelectronics (NYSE:UMC), Schmitt Industries (NASDAQ:SMIT)

  Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) announced Friday morning that EYLEA Injection demonstrated a significantly greater improvement in mean change in best-corrected visual acuity...

• Stocks

  Stocks In Focus: Telef (NYSE:TEF), Honeywell International Inc. (NYSE:HON), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

  Telefonica S.A. (ADR) (NYSE:TEF) declared that its plan to cut 1,600 full-time positions by 2018. The firm reported that the job reductions...